مرور بر اساس تاریخ انتشار Lucas, J

Showing results 1 to 4 of 4
PreviewIssue DateTitleContributor(s)
2018 JSM Supplement 2 June (13).pdf.jpg2018006 Bremelanotide for Hypoactive Sexual Desire Disorder: Integrated Subgroup Analysis According to FSFI Total Score at ScreeningClayton, A; Kingsberg, S; Derogatis, L; Simon, J; Jordan, R; Lucas, J
2018 JSM Volume15 Supplement 3 July (7).pdf.jpg2018007 Bremelanotide (BMT) for hypoactive sexual desire disorder (HSDD): efficacy analyses from the RECONNECT studiesClayton, A H; Kingsberg, S A; Simon, J; Jordan, R; Lucas, J
2018 JSM Volume15 Supplement 3 July (8).pdf.jpg2018008 Bremelanotide provides meaningful treatment benefits for premenopausal women with hypoactive sexual desire disorderKoochaki, P E; Revicki, D A; Wilson, H; Pokrzywinski, R; Jordan, R; Lucas, J
2018 JSM Supplement 2 June (9).pdf.jpg2018COMPOSITE ENDPOINTS FOR CLINICAL TRIALSRevicki, D; Althof, S; Derogatis, L; Kingsberg, S; Wilson, H; Jordan, R; Lucas, J
Showing results 1 to 4 of 4